Abort-for-profit ginat Planne Parenthood has been hit so hard by being cut off from Medicaid payments that its 'clinics' are offering Botox injections a much-needed additional source of income.
Planned Parenthood is in desperate need of new revenue streams after President Donald Trump’s One Big Beautiful Bill blocked the abortion giant from receiving federal Medicaid reimbursements.
As a result, Planned Parenthood Mar Monte (PPMM) — the organization’s largest affiliate that serves a vast area spanning Northern California and Nevada — has been forced to scramble to plug an estimated $100 million revenue gap, according to a report by The Wall Street Journal (WSJ).
What is unsaid in the WSJ puff piece is that PPMM needs to generate money in new ways in order to subsidize aborting preborn children.
PPMM has already had to close five facilities, reduce the number of programs it offers, and lay off about 15% of its staff.
And PPMM isn’t relying solely on Botox to boost its balance sheet.
“Now, along with access to birth control, abortions and testing for sexually transmitted infections, patients can order an IV hydration after a night of drinking — or smooth crow’s feet. They might soon be able to get laser hair removal and cosmetic fillers,” the Journal reported. “The centers are also adding nitrous oxide, or laughing gas, for intrauterine device insertions. And they are launching a telehealth concierge program for perimenopausal care, named Poppy after California’s state flower.”
“We’ll never fill this $100 million gap. It’s impossible,” said Stacy Cross, president and chief executive officer of PPMM. “But we have to do everything we can.”